16300 Addison Road Suite 120, Addison TX 75001

 
Supreme Labs

NEURODEGENERATIVE  DISEASES

Alzheimer 's | Dement ia | Parkinson's

NEURODEGENERATIVE DISEASES

PEOPLE WITH PARKINSON'S DISEASE GET DEMENTIA ABOUT 50% TO 80% OF THE TIME.

60% TO 80% OF PEOPLE WITH DEMENTIA HAVE ALZHEIMER'S

ALZHEIMER?S DISEASE IS BY FAR THE MOST COMMON FORM OF AGE-RELATED DEMENTIA.

50 MILLION

PEOPLE WORLDWIDE HAVE DEMENTIA, AND THERE ARE NEARLY 10 MILLION NEW CASES EVERY YEA

OVER 5 MILLION PEOPLE HAVE ALZHEIMER'S IN THE UNITED STATES

OVER 60,000 PEOPLE DIAGNOSED WITH PARKINSON'S EACH YEAR

15-25%

OF PEOPLE WITH PARKINSON'S REPORT HAVING A RELATIVE WITH THE DISEASE

THESE FAMILIAL CASES ARE CAUSED BY MUTATIONS IN THE LRRK2, PARK2, PARK7, PINK1, OR SNCA GENE

ALZHEIMER'S DISEASE IS CLASSIFIED AS EARLY ONSET VERSUS LATE ONSET, WITH 65 YEARS BEING THE DIVIDING THRESHOLD

THE MOST COMMON GENE ASSOCIATED WITH LATE-ONSET ALZHEIMER'S DISEASE RISK IS CALLED APOLIPOPROTEIN E (APOE). 
APOEHAS THREE COMMON FORMS: 
APOE E2 ? THE LEAST COMMON ? APPEARS TO REDUCE THE RISK OF ALZHEIMER'S. 
APOE E4 ? MOST COMMON ? INCREASES THE RISK OF ALZHEIMER'S. 
SINGLE COPY OF INHERITED GENE INCREASES RISK 2-3X. DOUBLE COPY INCREASES RISK 4-10X. 
APOE E3 ? THE MOST COMMON ? DOESN'T SEEM TO AFFECT THE RISK OF ALZHEIMER'S

NEURODEGENERATIVE PANEL

A2M
AAAS
ACE
APOE
APP
ATP13A2
ATP1A3
C9ORF72
CSF1R
EIF4G1
FBX07
GBA
GCH1
GRN
HTRA2
LRRK2
MAPT
MPO
NOTCH3
PARK7
PINK1
PLA2G6
PARK2
PRKRA
PRNP
PSEN1
PSEN2
SLC6A3
SNCA
SNCB
TAF1
TH
TREM2
TYROBP
UCHL1
VPS35
Supreme Medical Labs

Our ultimate goal is to improve health outcomes and to improve the quality of life for all patients.

EXPLORE:

This is text

Clia Certified
COLA Accreditation